Follow Us

 FacebookIcon.jpg  TwitterIcon.jpg  YouTubeIcon.jpg  InstagramIcon.jpg

Clinical Trials

Cancer - Breast Cancer

Title
BRCA Mutant Advanced or Metastatic Breast Cancer. EMBRACA
HER-2 Positive Breast Cancer With CNS Metastasis. TRIO B-09.
HER2 Positive Metastatic Breast Cancer for Patients Who Have Received Two or More Prior HER2 Directed Regimens.NALA-PUMA 301
Neoadjuvant Treatment for Early Stage Triple Negative Breast Cancer. GO29505
Stomatitis Prophylaxis Study for Stage IV Breast Cancer Patients Receiving Everolimus

Cancer - Colorectal Cancer

Title
Previously treated Metastatic Colorectal Cancer. INCB 18424-267.

Cancer - Heme Malignancies

Title
CLL 2nd line treatment for High Risk patients. UTX-IB-301
Heme Malignancies Serum Collection. BIO-001
Ublituximab + Ibrutinib in Select B-cell Malignancies.UTX-IB-104

Cancer - Hodgkin Lymphoma

Title
Frontline Treatment Trial for Patients With Advanced Classical Hodgkin Lymphoma.C25003

Cancer - Lung Cancer

Title
First line treatment for EGFR Mutant Advanced Non Small Cell Lung Cancer.TIGER-1.

Cancer - Melanoma

Title
A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma. BRIM8.

Cancer - Multiple Myeloma

Title
Newly Diagnosed Multiple Myeloma. Amgen 0482
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma

Cancer - Non-Hodgkin Lymphoma

Title
Idelalisib in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas. Yosemite
Frontline Treatment for CD30 Positive Diffuse Large B-cell Lymphoma and Follicular Lymphoma. SGN35-017

Cancer - Prostate Cancer

Title
Metastatic Castration Resistant Prostate Cancer. JNJ-56021927

Cancer - Breast Cancer

Title
C31001. Advanced or Metastatic Breast Cancer, ER Positive, Her2 Negative
Eisai-208. HER2 Positive Metastatic Breast Cancer

Cancer - GE & Stomach Cancer

Title
GE & Stomach Cancer - MM-111-13-02-04/Merrimack

Cancer - Lung Cancer

Title
NSCLC diagnosis assay development

Cancer - Breast Cancer

Title
Amgen D-Care. Denosumab for Early Stage Breast Cancer
Belle II. HER2 Negative, Metastatic Breast Cancer
For previously treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. MONARCH 1

Cancer - Lung Cancer

Title
ARCHER 1042. NSCLC (Stage IIIB/IV) 2nd Line
CA209-153. Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer - Multiple Myeloma

Title
Champion 2012-002. Multiple Myeloma Relapsing or Progressive Disease.

Cancer - Non-Hodgkin Lymphoma

Title
Bridalveil. Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
C05013. First line treatment DLBC Lymphoma

Cancer - Prostate Cancer

Title
NRX194204. Castration and Taxane resistant Prostate Cancer